
Stephen L. Rawlings
Examiner (ID: 18470, Phone: (571)272-0836 , Office: P/1643 )
| Most Active Art Unit | 1643 |
| Art Unit(s) | 1642, 1643, 1646 |
| Total Applications | 1483 |
| Issued Applications | 633 |
| Pending Applications | 153 |
| Abandoned Applications | 701 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5514115
[patent_doc_number] => 20090214421
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-27
[patent_title] => 'ANTIBODY DIRECTED AGAINST PAP2a AND USE THEREOF FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES'
[patent_app_type] => utility
[patent_app_number] => 11/914618
[patent_app_country] => US
[patent_app_date] => 2006-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 65
[patent_figures_cnt] => 65
[patent_no_of_words] => 32057
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20090214421.pdf
[firstpage_image] =>[orig_patent_app_number] => 11914618
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/914618 | Antibody directed against PAP2a and use thereof for diagnostic and therapeutic purposes | May 16, 2006 | Issued |
Array
(
[id] => 373258
[patent_doc_number] => 07473561
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-01-06
[patent_title] => 'Bone morphogenetic protein-2 in the treatment and diagnosis of cancer'
[patent_app_type] => utility
[patent_app_number] => 11/435852
[patent_app_country] => US
[patent_app_date] => 2006-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 32
[patent_no_of_words] => 23980
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 194
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/473/07473561.pdf
[firstpage_image] =>[orig_patent_app_number] => 11435852
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/435852 | Bone morphogenetic protein-2 in the treatment and diagnosis of cancer | May 16, 2006 | Issued |
Array
(
[id] => 5241835
[patent_doc_number] => 20070020327
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-25
[patent_title] => 'Inducing cellular immune responses to prostate cancer antigens using peptide and nucleic acid compositions'
[patent_app_type] => utility
[patent_app_number] => 11/418504
[patent_app_country] => US
[patent_app_date] => 2006-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 81417
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20070020327.pdf
[firstpage_image] =>[orig_patent_app_number] => 11418504
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/418504 | Inducing cellular immune responses to prostate cancer antigens using peptide and nucleic acid compositions | May 4, 2006 | Abandoned |
Array
(
[id] => 5850619
[patent_doc_number] => 20060233810
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-19
[patent_title] => 'Methods and compositions for treating or preventing cancer'
[patent_app_type] => utility
[patent_app_number] => 11/404967
[patent_app_country] => US
[patent_app_date] => 2006-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18827
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0233/20060233810.pdf
[firstpage_image] =>[orig_patent_app_number] => 11404967
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/404967 | Methods and compositions for treating or preventing cancer | Apr 13, 2006 | Abandoned |
Array
(
[id] => 4807439
[patent_doc_number] => 20080171017
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-17
[patent_title] => 'Use Of Cd25 Antibodies In Immunotherapy'
[patent_app_type] => utility
[patent_app_number] => 11/910805
[patent_app_country] => US
[patent_app_date] => 2006-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7571
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20080171017.pdf
[firstpage_image] =>[orig_patent_app_number] => 11910805
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/910805 | Use Of Cd25 Antibodies In Immunotherapy | Apr 12, 2006 | Abandoned |
Array
(
[id] => 4676804
[patent_doc_number] => 20080214435
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-04
[patent_title] => 'Novel Cancer Indications of Mannan-Binding Lectin (Mbl) in the Treatment of Immunocompromised Individuals'
[patent_app_type] => utility
[patent_app_number] => 11/911262
[patent_app_country] => US
[patent_app_date] => 2006-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10928
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20080214435.pdf
[firstpage_image] =>[orig_patent_app_number] => 11911262
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/911262 | Novel Cancer Indications of Mannan-Binding Lectin (Mbl) in the Treatment of Immunocompromised Individuals | Apr 5, 2006 | Abandoned |
Array
(
[id] => 12546951
[patent_doc_number] => 10011858
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-03
[patent_title] => Methods for producing polypeptides by regulating polypeptide association
[patent_app_type] => utility
[patent_app_number] => 11/910128
[patent_app_country] => US
[patent_app_date] => 2006-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 34555
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 900
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11910128
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/910128 | Methods for producing polypeptides by regulating polypeptide association | Mar 30, 2006 | Issued |
Array
(
[id] => 12546951
[patent_doc_number] => 10011858
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-03
[patent_title] => Methods for producing polypeptides by regulating polypeptide association
[patent_app_type] => utility
[patent_app_number] => 11/910128
[patent_app_country] => US
[patent_app_date] => 2006-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 34555
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 900
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11910128
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/910128 | Methods for producing polypeptides by regulating polypeptide association | Mar 30, 2006 | Issued |
Array
(
[id] => 12546951
[patent_doc_number] => 10011858
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-03
[patent_title] => Methods for producing polypeptides by regulating polypeptide association
[patent_app_type] => utility
[patent_app_number] => 11/910128
[patent_app_country] => US
[patent_app_date] => 2006-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 34555
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 900
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11910128
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/910128 | Methods for producing polypeptides by regulating polypeptide association | Mar 30, 2006 | Issued |
Array
(
[id] => 12546951
[patent_doc_number] => 10011858
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-03
[patent_title] => Methods for producing polypeptides by regulating polypeptide association
[patent_app_type] => utility
[patent_app_number] => 11/910128
[patent_app_country] => US
[patent_app_date] => 2006-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 34555
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 900
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11910128
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/910128 | Methods for producing polypeptides by regulating polypeptide association | Mar 30, 2006 | Issued |
Array
(
[id] => 7550555
[patent_doc_number] => 08062887
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-11-22
[patent_title] => 'Monoclonal antibody specifically recognizing modification site after translation of p53 and kit for assaying modification site containing the same'
[patent_app_type] => utility
[patent_app_number] => 11/910313
[patent_app_country] => US
[patent_app_date] => 2006-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 14
[patent_no_of_words] => 15328
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/062/08062887.pdf
[firstpage_image] =>[orig_patent_app_number] => 11910313
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/910313 | Monoclonal antibody specifically recognizing modification site after translation of p53 and kit for assaying modification site containing the same | Mar 30, 2006 | Issued |
Array
(
[id] => 5666600
[patent_doc_number] => 20060171950
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-03
[patent_title] => 'USE OF CD23 ANTAGONISTS FOR THE TREATMENT OF NEOPLASTIC DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 11/277982
[patent_app_country] => US
[patent_app_date] => 2006-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 22613
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20060171950.pdf
[firstpage_image] =>[orig_patent_app_number] => 11277982
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/277982 | USE OF CD23 ANTAGONISTS FOR THE TREATMENT OF NEOPLASTIC DISORDERS | Mar 29, 2006 | Abandoned |
Array
(
[id] => 5608039
[patent_doc_number] => 20060269555
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-30
[patent_title] => 'Antibodies that immunospecifically bind to TRAIL receptors'
[patent_app_type] => utility
[patent_app_number] => 11/391395
[patent_app_country] => US
[patent_app_date] => 2006-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 136850
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20060269555.pdf
[firstpage_image] =>[orig_patent_app_number] => 11391395
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/391395 | Antibodies that immunospecifically bind to TRAIL receptors | Mar 28, 2006 | Abandoned |
Array
(
[id] => 5704822
[patent_doc_number] => 20060193870
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-31
[patent_title] => 'Compositions and methods for the therapy and diagnosis of colon cancer'
[patent_app_type] => utility
[patent_app_number] => 11/374388
[patent_app_country] => US
[patent_app_date] => 2006-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 68573
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0193/20060193870.pdf
[firstpage_image] =>[orig_patent_app_number] => 11374388
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/374388 | Compositions and methods for the therapy and diagnosis of colon cancer | Mar 12, 2006 | Abandoned |
Array
(
[id] => 83301
[patent_doc_number] => 07741111
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-06-22
[patent_title] => 'Pregnancy, up-regulated non-ubiquitous CaM kinase'
[patent_app_type] => utility
[patent_app_number] => 11/374353
[patent_app_country] => US
[patent_app_date] => 2006-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 19501
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/741/07741111.pdf
[firstpage_image] =>[orig_patent_app_number] => 11374353
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/374353 | Pregnancy, up-regulated non-ubiquitous CaM kinase | Mar 12, 2006 | Issued |
Array
(
[id] => 4839380
[patent_doc_number] => 20080279865
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-13
[patent_title] => 'Therapy of Prostate Cancer With Ctla-4 Antibodies and Hormonal Therapy'
[patent_app_type] => utility
[patent_app_number] => 11/817390
[patent_app_country] => US
[patent_app_date] => 2006-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 25734
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0279/20080279865.pdf
[firstpage_image] =>[orig_patent_app_number] => 11817390
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/817390 | Therapy of Prostate Cancer With Ctla-4 Antibodies and Hormonal Therapy | Mar 2, 2006 | Abandoned |
Array
(
[id] => 5056802
[patent_doc_number] => 20070059724
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-15
[patent_title] => 'Novel compositions and methods for lymphoma and leukemia'
[patent_app_type] => utility
[patent_app_number] => 11/365889
[patent_app_country] => US
[patent_app_date] => 2006-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45074
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20070059724.pdf
[firstpage_image] =>[orig_patent_app_number] => 11365889
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/365889 | Novel compositions and methods for lymphoma and leukemia | Feb 28, 2006 | Abandoned |
Array
(
[id] => 204331
[patent_doc_number] => 07629144
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-12-08
[patent_title] => 'Secreted epithelial colon stromal-1 molecules and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/364871
[patent_app_country] => US
[patent_app_date] => 2006-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 33131
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/629/07629144.pdf
[firstpage_image] =>[orig_patent_app_number] => 11364871
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/364871 | Secreted epithelial colon stromal-1 molecules and uses thereof | Feb 27, 2006 | Issued |
Array
(
[id] => 5649700
[patent_doc_number] => 20060135435
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-22
[patent_title] => 'Agent that retards transformation of hormone-dependent cancer to non-hormone-dependent cancer'
[patent_app_type] => utility
[patent_app_number] => 11/363447
[patent_app_country] => US
[patent_app_date] => 2006-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5889
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0135/20060135435.pdf
[firstpage_image] =>[orig_patent_app_number] => 11363447
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/363447 | Agent that retards transformation of hormone-dependent cancer to non-hormone-dependent cancer | Feb 26, 2006 | Abandoned |
Array
(
[id] => 11635115
[patent_doc_number] => 09657074
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-23
[patent_title] => 'Enzymatic large-scale synthesis of mucin glyconjugates, and immunogenic applications thereof'
[patent_app_type] => utility
[patent_app_number] => 12/160605
[patent_app_country] => US
[patent_app_date] => 2006-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 22
[patent_no_of_words] => 24652
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12160605
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/160605 | Enzymatic large-scale synthesis of mucin glyconjugates, and immunogenic applications thereof | Feb 22, 2006 | Issued |